Johnson & Johnson is a global holding company that engages in the research and development, manufacture and sale of a range of products in the healthcare field. The company operates in three business segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes a range of products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women’s health, and wound care markets. The Pharmaceutical segment is focused on the therapeutic areas of immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolism, as well as pulmonary hypertension. The Medical Devices segment includes a range of products used in the orthopedic, surgery, interventional solutions, and eye health fields.
Its major brands include:
Type | Public | |
Founded | 1886 | |
HQ | New Brunswick, NJ, US | Map |
Website | jnj.com | |
Employee Ratings | More | |
Overall Culture | C+ | More |
USD | |
---|---|
Revenue (Q3, 2020) | 21.1b |
Gross profit (Q3, 2020) | 14.1b |
Gross profit margin (Q3, 2020), % | 66.9% |
Net income (Q3, 2020) | 3.6b |
Market capitalization (19-Feb-2021) | 429.1b |
Closing stock price (19-Feb-2021) | 163.0 |
Cash (27-Sept-2020) | 19.0b |
EV | 447.8b |
USD | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 17.8b | 18.8b | 19.7b | 20.0b | 20.8b | 20.3b | 20.0b | 20.6b | 20.7b | 20.7b | 18.3b | 21.1b |
Cost of goods sold | 5.4b | 5.8b | 6.9b | 6.6b | 6.9b | 6.6b | 6.6b | 6.9b | 6.9b | 7.1b | 6.6b | 7.0b |
Gross profit | 12.4b | 13.0b | 12.7b | 13.4b | 13.9b | 13.8b | 13.4b | 13.6b | 13.9b | 13.6b | 11.8b | 14.1b |
Gross profit Margin, % | 70% | 69% | 65% | 67% | 67% | 68% | 67% | 66% | 67% | 66% | 64% | 67% |
USD | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 20.9b | 12.6b | 15.7b | 14.6b | 17.6b | 16.1b | 14.7b | 14.4b | 16.2b | 15.5b | 11.2b | 19.0b |
Accounts Receivable | 12.3b | 13.3b | 13.2b | 14.2b | 14.1b | 14.0b | 14.1b | 14.7b | 14.8b | 14.9b | 14.6b | 14.6b |
Prepaid Expenses | 2.8b | 3.0b | 2.9b | 2.6b | 2.6b | 2.9b | 2.6b | 2.4b | 2.2b | 2.4b | 2.6b | 2.5b |
Inventories | 8.9b | 9.7b | 9.5b | 9.0b | 8.8b | 8.7b | 9.1b | 9.3b | 9.2b | 8.9b | 9.4b | 9.6b |
USD | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 4.4b | 8.2b | 12.0b | 4.4b | 8.3b | 12.3b | 3.7b | 9.4b | 11.1b | 5.8b | 9.4b | 13.0b |
Depreciation and Amortization | 912.0m | 2.1b | 3.8b | 1.7b | 3.5b | 5.2b | 1.8b | 3.5b | 5.2b | 1.7b | 3.5b | 5.3b |
Inventories | (368.0m) | (421.0m) | (193.0m) | (322.0m) | (491.0m) | (777.0m) | (369.0m) | (423.0m) | (424.0m) | (159.0m) | (637.0m) | (784.0m) |
Accounts Payable | (2.0b) | (1.2b) | 339.0m | (1.7b) | (49.0m) | 731.0m | (1.8b) | (444.0m) | 2.3b | (2.5b) | (2.3b) | (119.0m) |
USD | Q1, 2018 |
---|---|
Debt/Equity | 0.5 x |
Debt/Assets | 0.2 x |
Financial Leverage | 2.1 x |
Company Name | Date | Deal Size |
---|---|---|
Momenta Pharmaceuticals | August 19, 2020 | $6.50 b |
TARIS Biomedical | December 20, 2019 | |
Verb Surgical | December 20, 2019 | |
Auris Health | January 23, 2019 | $3.40 b |
Ci:z Holdings | October 23, 2018 | $2.10 b |
Zarbee's Naturals | July 27, 2018 | |
Orthotaxy | February 20, 2018 | |
Actelion Pharmaceuticals | January 26, 2017 | $30 b |
Abott Medical Optics | September 16, 2016 | $4.33 b |
Vogue International | June 02, 2016 | $3.30 b |
Johnson & Johnson revenue breakdown by business segment: 31.6% from Medical Devices, 51.4% from Pharmaceutical and 16.9% from Consumer
Johnson & Johnson revenue breakdown by geographic segment: 19.0% from Asia-Pacific, Africa, 7.2% from Western Hemisphere excluding US, 22.5% from Europe and 51.3% from United States
Johnson & Johnson has 219.04k Twitter Followers. The number of followers has increased 1.9% month over month and increased 4.7% quarter over quarter
14.5k
Tweets
2.5k
Following
219k
Followers
55
Tweets last 30 days
42
Avg. likes per Tweet
83.6%
Tweets with engagement
C+
72/100
D-
62/100
D
54/100
When was Johnson & Johnson founded?
Johnson & Johnson was founded in 1886.
Who are Johnson & Johnson key executives?
Johnson & Johnson's key executives are Alex Gorsky, Joaquin Duato and Peter Fasolo.
How many employees does Johnson & Johnson have?
Johnson & Johnson has 132,200 employees.
What is Johnson & Johnson revenue?
Latest Johnson & Johnson annual revenue is $82.1 b.
What is Johnson & Johnson revenue per employee?
Latest Johnson & Johnson revenue per employee is $620.7 k.
Who are Johnson & Johnson competitors?
Competitors of Johnson & Johnson include Bayer, Pfizer and Procter & Gamble.
Where is Johnson & Johnson headquarters?
Johnson & Johnson headquarters is located at 1 Johnson And Johnson Plaza, New Brunswick.
Where are Johnson & Johnson offices?
Johnson & Johnson has offices in New Brunswick, Jacksonville, Lancaster, Piscataway and in 66 other locations.
How many offices does Johnson & Johnson have?
Johnson & Johnson has 73 offices.
Receive alerts for 300+ data fields across thousands of companies